Michigan Institute for Clinical & Health Research

What Michigan Institute for Clinical & Health Research does

The Michigan Institute for Clinical and Health Research (MICHR) is a translational science research institute within the University of Michigan, founded in 2006 and funded primarily by the NIH National Center for Advancing Translational Sciences (NCATS) through the Clinical and Translational Science Award (CTSA) program, of which it has been a designated awardee since 2007. Its $71 million 2023 CTSA grant (UM1TR004404) anchors a seven-year funding runway through 2030 and situates MICHR within a national consortium of more than 60 academic research institutions. MICHR's core offering is an integrated suite of programs covering the full translational research lifecycle: team building, education and mentoring (Clinical Trials Academy, K Writing Workshop, Predoctoral/Postdoctoral T32s, STEP.up), study design and biostatistics, IND/IDE regulatory support, participant recruitment (UMHealthResearch.org volunteer registry with 104,000+ participants), informatics tools (EMERSE, REDCap, i2b2/SHRINE), community engagement, dissemination and implementation science, and pilot grant funding. The institute employs 101-250 staff (113 listed on the website) across programs such as BRISP, Biostatistics, Community Engagement, Informatics, and Team Science.

MICHR's proprietary technology stack centers on EMERSE, an open-source Electronic Medical Record Search Engine developed since 2005 that uses natural language processing with synonym libraries and negation/context recognition to search free-text clinical notes; a 2026 upgrade added optical character recognition for scanned and handwritten documents. EMERSE supports nearly 700 studies at Michigan Medicine and is deployed at almost 20 sites nationwide. The business model is hybrid: the CTSA grant underwrites the majority of operations as a quasi-recurring federal award, while a fee-for-service recharge layer (e.g., $100/hour biostatistics, $100/hour REDCap development, $90/hour IND/IDE support, $250/hour neurodevelopmental assessment) supplements revenue from internal Michigan Medicine users, Wayne State University-EACPHS affiliates, and external institutions. Primary customers are University of Michigan researchers and clinical research staff, with secondary segments including community and patient partners, affiliate physicians, and partner-institution researchers (Wayne State, Ohio State, Rochester, Tufts through DIAMOND). Distribution is direct-to-institution via the MICHR website, consultation requests, workshops, and the Breakthrough newsletter.

Name

Michigan Institute for Clinical & Health Research

Legal name

Michigan Institute for Clinical & Health Research

Website

https://michr.umich.edu

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

MICHR is the University of Michigan's NIH-funded translational science institute, delivering consulting, training, informatics tools (EMERSE, REDCap, UMHealthResearch.org), and pilot grants to U-M researchers, community partners, and the national CTSA consortium.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Clinical research support
• Translational science services
• Biostatistics consulting
• Research informatics tools
• Clinical trial assistance

Headquarters

HQ city

Michigan

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. NIH CTSA Grant Funding: Primary funding from NIH National Center for Advancing Translational Sciences (NCATS) through the Clinical and Translational Science Award (CTSA) program. The 2023 seven-year grant is valued at $71 million.
2. Fee-for-Service Consulting and Support: MICHR provides various fee-based services including biostatistics consultation ($100/hour), database development ($100/hour), IND/IDE support ($90/hour), and neurodevelopmental assessments ($250/hour). Reduced rates and no-charge services are possible due to federal funding.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

MICHR is a centralized translational research support institute within the University of Michigan that delivers a comprehensive suite of programs and services across the clinical and translational research lifecycle. Offerings include biostatistics consultation, informatics tools (EMERSE, REDCap, UMHealthResearch.org), regulatory IND/IDE support, pilot grant funding, community engagement, team science facilitation, participant recruitment, and clinical trials training. Services are delivered to U-M researchers and affiliated partners through consultations, workshops, and fee-based or grant-subsidized engagements.

Product overview

MICHR (Michigan Institute for Clinical & Health Research) is an organizational resource center rather than a traditional software product. It operates as part of the NIH CTSA Program consortium with over 60 academic research institutions. MICHR provides a comprehensive suite of clinical and translational research support services organized into distinct programs: the Informatics Program (offering REDCap, EMERSE, and UMHealthResearch.org tools), Biostatistics Program, Behavioral Research Innovation & Support Program (BRISP), Community Engagement Program, Dissemination & Implementation Science Catalyst, Education and Mentoring Group (EMG) with the DIAMOND Portal, Interdisciplinary Research and Team Science Program, IND/IDE Assistance Program, Network Based Research Program, Participant Recruitment Program, Pilot Grant Program, Translational Innovation Program, and Study Management and Monitoring Program. These programs collectively support research teams across the entire translational research pipeline from team building through study design, funding, implementation, and dissemination.

Differentiator

Problem solved

Functional benefit

Brands

• BRISP: Behavioral Research Innovation & Support Program - provides support, consultation, and training to enhance rigor in conducting behavioral and social science research.
• EMERSE
• DIAMOND Portal
• STEP.up
• Clinical Trials Academy (CTA)

Products and services

• Behavioral Research Innovation & Support Program (BRISP)
• Biostatistics Program
• Community Engagement Program
• Dissemination & Implementation Science Catalyst (DISC-ISN)
• EMERSE (Electronic Medical Record Search Engine)
• REDCap (Research Electronic Data Capture)
• UMHealthResearch.org
• MICHR IND/IDE Investigator Assistance Program (MIAP)
• Pilot Grant Program
• Network Based Research Program
• Participant Recruitment Program
• Translational Innovation Program (TIP)
• Study Management and Monitoring Program
• Interdisciplinary Research and Team Science Program
• DIAMOND Portal
• Clinical Trials Academy: Protocol Development (CTA1)
• Clinical Trials Academy: Protocol Execution (CTA2)
• Translational Science Hub

Quantifiable outcome

• Over 104,000 volunteer registry participants matched to studies through UMHealthResearch
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• NIH National Center for Advancing Translational Sciences (NCATS)coreStrategic or Co-development Partner · 1 January 2023MICHR is a CTSA Program awardee receiving primary funding through the NIH NCATS. The CTSA Program includes over 60 academic research institutions working together to improve the process of translational research. The current grant (UM1TR004404) was awarded in 2023 for seven years.
• Cureus Journal of Medical Science (Springer Nature)coreStrategic or Co-development PartnerThe Translational Science Hub (The Hub) is hosted by Cureus Journal of Medical Science, part of Springer Nature. This free, open-access space allows researchers to share translational science content including posters, reports, and peer-reviewed articles.
• Ohio State UniversityminorStrategic or Co-development PartnerCollaborated with Ohio State University to create the DIAMOND (Development, Implementation, and AssessMent Of Novel Training in Domain-based competencies) portal, a federated database for sharing training and assessment resources for clinical and translational research teams.
• Rochester UniversityminorStrategic or Co-development PartnerCollaborated with Rochester University to create the DIAMOND portal for sharing training and assessment resources across CTSA consortium institutions.
• Tufts UniversityminorStrategic or Co-development PartnerCollaborated with Tufts University to create the DIAMOND portal for sharing training and assessment resources across CTSA consortium institutions.
• Detroit URC (Urban Research Center)minorStrategic or Co-development PartnerMICHR partners with the Detroit URC twice yearly to implement training on community-engaged research between community and academic partners.
• PCORI (Patient-Centered Outcomes Research Institute)coreStrategic or Co-development PartnerMICHR participates in PCORnet, the National Patient-Centered Clinical Research Network. The PaTH to Patient-Centered Health and Health Care project was awarded four more years of funding (2025-2029) by PCORI.
• Trial Innovation Network (TIN)coreStrategic or Co-development PartnerMICHR participates in the NIH NCATS CTSA Program Trial Innovation Network, connecting Michigan Medicine faculty with national trial opportunities.
• PaTH Clinical Research NetworkcoreStrategic or Co-development PartnerMICHR's Network Based Research Program participates in PaTH Patient Empowered Research, bringing faculty-initiated proposals to the network for multisite participation.
• National Clinical Cohort Collaborative (N3)minorStrategic or Co-development PartnerMICHR participates in the NIH NCATS National Clinical Cohort Collaborative through its Network Based Research Program.
• U-M Medical School Office of Faculty DevelopmentminorStrategic or Co-development PartnerCo-sponsors the annual Mentoring Forum with MICHR to honor research mentors at the University of Michigan.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Vanderbilt Institute for Clinical and Translational Research (VICTR): Vanderbilt's CTSA hub, structurally identical to MICHR: NIH-funded translational research support institute providing biostatistics, informatics (including ResearchMatch), pilot funding, and training across the translational pipeline.
• Harvard Catalyst: Harvard's CTSA hub offering research support services across the translational lifecycle — biostatistics, regulatory, informatics, community engagement, and pilot funding — directly comparable to MICHR's program portfolio.
• Northwestern University Clinical and Translational Sciences Institute (NUCATS): Northwestern's CTSA hub with a comparable suite of translational research support services including informatics, biostatistics, and pilot grants. Directly comparable in scope and operating model.
• UCSF Clinical and Translational Science Institute (CTSI): UCSF's CTSA hub providing translational research infrastructure including informatics tools, biostatistics, participant recruitment, and training — a like-for-like peer within the CTSA consortium.
• Duke Clinical and Translational Science Institute: Duke's CTSA hub offering research navigation, biostatistics, informatics, and community engagement. Operates with the same NIH CTSA funding model and provides directly comparable services.
• University of Pennsylvania Institute for Translational Medicine and Therapeutics (ITMAT): UPenn's CTSA-supported translational research institute offering education, pilot funding, and research support services. Direct CTSA peer in the same funding and operating framework.
• Tufts Clinical and Translational Science Institute (CTSI): Tufts' CTSA hub and a direct collaborator with MICHR on the DIAMOND portal. Provides an analogous suite of translational research support services to its regional research community.
• Ohio State University Center for Clinical and Translational Science: Ohio State's CTSA hub, a close collaborator on the DIAMOND federated training platform. Comparable operating model and service portfolio; co-develops shared national CTSA resources with MICHR.
• University of Rochester Clinical and Translational Science Institute: Rochester's CTSA hub and DIAMOND portal co-developer. Operates the same NIH-funded translational research support model with biostatistics, informatics, and pilot funding.
• ConduITS (Icahn School of Medicine at Mount Sinai): Mount Sinai's CTSA hub providing translational research services including clinical trials support, informatics, and biostatistics. A direct CTSA consortium peer with similar scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/UM_MICHR
• LinkedInlinkedin.com/company/michr

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michigan Institute for Clinical & Health Research